Clinical Trials · NCT05132088
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 201
- Start date
- Nov 2021
- Locations
- 13 sites, Japan, South Korea
- Primary endpoint
- Relative change in body weight